Correlation Between Femasys and ReShape Lifesciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Femasys and ReShape Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Femasys and ReShape Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Femasys and ReShape Lifesciences, you can compare the effects of market volatilities on Femasys and ReShape Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Femasys with a short position of ReShape Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Femasys and ReShape Lifesciences.

Diversification Opportunities for Femasys and ReShape Lifesciences

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between Femasys and ReShape is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Femasys and ReShape Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ReShape Lifesciences and Femasys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Femasys are associated (or correlated) with ReShape Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ReShape Lifesciences has no effect on the direction of Femasys i.e., Femasys and ReShape Lifesciences go up and down completely randomly.

Pair Corralation between Femasys and ReShape Lifesciences

Given the investment horizon of 90 days Femasys is expected to generate 0.56 times more return on investment than ReShape Lifesciences. However, Femasys is 1.8 times less risky than ReShape Lifesciences. It trades about -0.03 of its potential returns per unit of risk. ReShape Lifesciences is currently generating about -0.07 per unit of risk. If you would invest  117.00  in Femasys on August 30, 2024 and sell it today you would lose (13.00) from holding Femasys or give up 11.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Femasys  vs.  ReShape Lifesciences

 Performance 
       Timeline  
Femasys 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Femasys has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
ReShape Lifesciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ReShape Lifesciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Femasys and ReShape Lifesciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Femasys and ReShape Lifesciences

The main advantage of trading using opposite Femasys and ReShape Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Femasys position performs unexpectedly, ReShape Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ReShape Lifesciences will offset losses from the drop in ReShape Lifesciences' long position.
The idea behind Femasys and ReShape Lifesciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes